| A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene N Magusali, AC Graham, TM Piers, P Panichnantakul, U Yaman, M Shoai, ... Brain 144 (12), 3727-3741, 2021 | 94 | 2021 |
| Liposome-based combination therapy for acne treatment İ Eroğlu, M Aslan, Ü Yaman, M Gultekinoglu, S Çalamak, D Kart, ... Journal of liposome research 30 (3), 263-273, 2020 | 37 | 2020 |
| Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line Ü Yaman, M Aslan, S Ozturk, K Ulubayram, İ Eroğlu Pharmaceutical Development and Technology 25 (10), 1192-1203, 2020 | 12 | 2020 |
| Genetic variability associated with OAS1 expression in myeloid cells increases the risk of Alzheimer’s disease and severe COVID-19 outcomes N Magusali, AC Graham, TM Piers, P Panichnantakul, U Yaman, M Shoai, ... bioRxiv, 2021.03. 16.435702, 2021 | 5 | 2021 |
| İntratümöral Uygulamaya Yönelik Nanolipozom Formülasyonlarının Geliştirilmesi Ü Yaman Fen Bilimleri Enstitüsü, 2019 | 2 | 2019 |
| Chromosome X-wide association study in case control studies of pathologically confirmed Alzheimer’s disease in a European population E Simmonds, G Leonenko, U Yaman, E Bellou, A Myers, K Morgan, ... Translational Psychiatry 14 (1), 358, 2024 | 1 | 2024 |
| The fifth international hackathon for developing computational cloud-based tools and resources for pan-structural variation and genomics SK Deb, D Kalra, J Kubica, E Stricker, VQ Truong, Q Zeng, CJ Fiscus, ... F1000Research 13, 708, 2024 | 1 | 2024 |
| Genetic variation associated with human longevity and Alzheimer’s disease risk act through microglia and oligodendrocyte cross-talk AC Graham, E Bellou, JC Harwood, U Yaman, M Celikag, N Magusali, ... medRxiv, 2023.03. 30.23287975, 2023 | 1 | 2023 |
| Microglia produce the amyloidogenic ABri peptide in familial British dementia C Arber, JM Casey, S Crawford, N Rambarack, U Yaman, S Wiethoff, ... bioRxiv, 2023.06. 27.546552, 2023 | 1 | 2023 |
| Microglia contribute to the production of the amyloidogenic ABri peptide in familial British dementia C Arber, JM Casey, S Crawford, N Rambarack, U Yaman, S Wiethoff, ... Acta Neuropathologica 148 (1), 1-16, 2024 | | 2024 |
| Exploratory Blood Biomarker Patterns in a Mixed Dementia Cohort H Gezegen, M Alaylioglu, E Sahin, O Swann, E Veleva, G Guven, ... medRxiv, 2024.11. 07.24316927, 2024 | | 2024 |
| Long-read transcriptomic identification of synaptic adaptation to amyloid pathology in the App (NL-GF) knock-in mouse model of the earliest phase of Alzheimer's disease U Yaman, G Banks, EK Gustavsson, P Mumford, N Magusali, OS Taso, ... bioRxiv, 2024.08. 10.607237, 2024 | | 2024 |
| Genetic variability associated withOAS1expression in myeloid cells increases the risk of Alzheimer’s disease and severe COVID-19 outcomes N Magusali, AC Graham, TM Piers, P Panichnantakul, U Yaman, M Shoai, ... | | 2021 |
